Gilead Sciences Inc
NASDAQ: GILD · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
Updated 2026-04-29
Gilead Sciences Inc (GILD) Stock Valuation Analysis
Fair value estimate, historical valuation range, and quality signals for GILD.
Valued
Valuation reasonably reflects current fundamentals. Limited margin of safety at these levels.
GILD historical valuation range
Where current P/E sits in GILD's own 5Y range.
GILD intrinsic value (DCF)
DCF-based fair value estimate vs current market price.
Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.
GILD valuation signals
Quick-read green flags, caution flags, and risks based on current metrics.
P/E Ratio — History
Current: 19.23x
P/S Ratio — History
Current: 5.50x
Is GILD overvalued in 2026?
Gilead Sciences Inc (GILD) currently trades at $130.84 per share with a market capitalization of $161,852,948,000.00. Based on our multi-factor framework, the stock trades at a fair valuation with a Smart Value Score of 72/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.
The stock trades at a P/E ratio of 19.2x, above its 5-year median of 17.7x. The PEG ratio of 0.36 suggests earnings growth is outpacing the multiple, a classic sign of undervaluation.
Looking at its own history, GILD is currently trading more expensive than 68% of the last 5Y on P/E. This places it in the 68th percentile of its historical range, a reasonable but unremarkable position.
Our discounted cash flow model estimates GILD's intrinsic value at $237.26 per share, against the current market price of $130.84. This implies a margin of safety of +45.70%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.
The Piotroski F-Score of 6/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.
Bottom line: GILD trades at a fair valuation on our framework, with a Smart Value Score of 72/100. The valuation is defensible but offers no obvious bargain. Patience or a better entry price may reward disciplined buyers.
Frequently asked questions
Is GILD overvalued in 2026?
Based on a Smart Value Score of 72/100, GILD is fairly valued. Price reasonably reflects current fundamentals with limited cushion in either direction.
What is GILD's fair value?
Our DCF model estimates GILD's intrinsic value at $237.26 per share, versus the current price of $130.84. This produces a margin of safety of +45.70%.
What P/E ratio does GILD trade at?
GILD trades at a P/E of 19.2x on trailing twelve-month earnings, compared to its 5-year median of 17.7x.
Is GILD a buy based on valuation?
WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 72/100 reflects the combined read on growth, quality, and price. The profile is balanced. Best suited for investors with an existing thesis.
How does GILD's valuation compare to its history?
On P/E, GILD currently sits in the 68th percentile of its own 5Y range. That is above its long-run median relative to where it has traded over the period.
What is GILD's Smart Value Score?
GILD's Smart Value Score is 72/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.